Maharashtra- based Transpact Enterprises Limited is a biotechnology startUp. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products.
| Bidding Dates |
|---|
| 26 Aug 2019 - 28 Aug 2019 |
| Subscription |
|---|
| 1.13x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,30,000 | 1 | 2 | 1000 | 104.0 K | ₹130 | 73.11 % | ₹13.5 M | RHP DOC |
Transpact Enterprises IPO SUBSCRIPTION STATUS
28 Aug '19Transpact Enterprises IPO overall subscription rate was 1.13 times the total available shares
Transpact Enterprises IPO retail subscription rate was 1.37 times in the retail segment
Transpact Enterprises IPO non-institutional investor subscription rate was 0.9 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
28 Aug 2019 (Day 6) | 1.37x | 0.9x | - |
26 Aug 2019 (Day 2) | 1x | 0.67x | - |
27 Aug 2019 (Day 4) | 1.14x | 0.82x | - |
26 Aug 2019 (Day 1) | 1x | 0.67x | - |
27 Aug 2019 (Day 3) | 1.14x | 0.82x | - |
28 Aug 2019 (Day 5) | 1.37x | 0.9x | - |
Transpact Enterprises FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from operations (Rs in millions) | Cash Flow from operations (Rs in millions) | Free Cash flow (Rs in millions) |
| FY19 | -0.7 | 1.3 | -0.6 | -1.3 |
| FY18 | -0.9 | -1.1 | -2.4 | |
| FY17 | -0.5 | -0.5 | -1.0 |
Transpact Enterprises IPO SUBSCRIPTION STATUS DETAILS
Transpact Enterprises had 104.0 K shares on offer
Transpact Enterprises IPO offer price was ₹130
Transpact Enterprises IPO minimum Investment was ₹130000
Transpact Enterprises IPO issue size was ₹ 13.5 M
Transpact Enterprises had a minimum lot size of 1000 Shares per application
Transpact Enterprises NUMBER OF SHARES ON OFFER
Transpact Enterprises IPO IMPORTANT DATES
| Issue Open Date | 26 Aug 2019 |
| Issue close Date | 28 Aug 2019 |
| Allotment Date | 03 Sep 2019 |
| Refund Date | 04 Sep 2019 |
| Demat Account Credit Date | 05 Sep 2019 |
| Listing Date | 06 Sep 2019 |
| Listing on Exchange(s) | BSE |
| Transpact Enterprises Allotment Status | Exchange |
Transpact Enterprises IPO subscription opened on 26 Aug 2019, and closed on 28 Aug 2019
IPO allotment for Transpact Enterprises was finalized on Tuesday, 03 Sep 2019
IPO listing for Transpact Enterprises was on BSE on Friday, 06 Sep 2019
Transpact Enterprises IPO LISTING GAINS
| Issue Price (adjusted) | 130.0 |
| Listing Open Price | 132.5 |
| Listing Close Price | 131.0 |
| Listing Gain% | 1.9% |
| Current Gain% | -18.9% |
Transpact Enterprises Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transpact Enterprises Ltd. | 105.4 | 4.1 | 47.2 | 0.1 | 22.7 | 16.2 | 11.1 | 0.2 | 118.2 | 0.1 | 860 | 2.2 | 860 |
| Poly Medicure Ltd. | 1772.4 | 17965.3 | 57 | -4.8 | 9 | 10.4 | 8.2 | 1995.3 | 13.4 | 322.1 | -4.8 | 31.1 | -11.9 |
| Medplus Health Services Ltd. | 686.3 | 8245 | 39.2 | 2.2 | 1.1 | 11.1 | 5.6 | 6963.8 | 12.6 | 219.6 | 46.1 | 17.5 | 18 |
| Q-Line Biotech Ltd. | 535.8 | 1249.9 | 22.4 | 22.6 | 10 | 347.4 | 7.7 | 55.7 | 98.1 | 23.9 | |||
| Laxmi Dental Ltd. | 215.6 | 1184.8 | 40.9 | -4.7 | 4.3 | 11.9 | 9.8 | 286.4 | 18.1 | 29 | -8.8 | 5.3 | -8.8 |
| Vasa Denticity Ltd. | 421.6 | 700.7 | 70.7 | -2.3 | 2.3 | 5.7 | 5 | 283.4 | 12.8 | 9.9 | -41.6 | 6 | -31.3 |
Transpact Enterprises INFORMATION ON IPO ISSUE
About Transpact Enterprises
Maharashtra- based Transpact Enterprises Limited is a biotechnology startUp. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products.
Object of the Issue
- Redemption of Preference Shares
- Acquisition of R & D facility and Registered Office on a long-term basis
- General Corporate Purpose
Transpact Enterprises - PROMOTERS
| Name |
|---|
| Aslam Khan |
| Anis Choudhery |
Transpact Enterprises Book Running Lead Manager
Aryaman Financial Services Limited
ipo@afsl.co.in
Transpact Enterprises Registrar to the Offer
Bigshare Services Private Limited
ipo@bigshareonline.com
Transpact Enterprises Strengths
User Friendly Device
The company's device- Vestibulator is user friendly, and has the following features: a. It has a separate console for the operator. b. It is a child-friendly device. The device is bio-compatible. c. It has safety-tested measures for patients & operators. d. It also reduces the physical efforts of the therapist. The company believes that these benefits of our device will help us to attract well-known therapists and other health care professionals from a diverse talent pool
Quality Assurance
The Company is an ISO 13485:2016 certified company for “Medical devices” and ISO 9001:2015 certified for the quality management systems.
Transpact Enterprises Risks
Recently commerlized product
The product is a unique and innovative therapeutic design that has been recently commercialized. If the same is not accepted in the market as per our expectations, business, results of operations and financial condition may be adversely affected.
Possibility of side effects
If the device causes or is perceived to cause any severe side effects, the company's reputation, revenues and profitability could be adversely affected.
IPO FAQs
The promoters of the company are Aslam Khan and Anis Choudhery.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 130.0 - 130.0.
The IPO application opens on Aug 26, 2019 and closes on Aug 28, 2019.
The minimum lot size for the IPO is 1000. The maximum lot size for the IPO is 1000.
For all category investors, the minimum application amount for this IPO is Rs. 130,000.0, the maximum value for this IPO is Rs 130,000.0.
This IPO will be allotted on Sep 03, 2019.
The refund will be credited to your account on Sep 04, 2019.
The allotted shares will be credited to your demat on Sep 05, 2019.
Transpact Enterprises Ltd.’s shares listed on the stock exchanges on Sep 06, 2019.